<DOC>
	<DOCNO>NCT01125631</DOCNO>
	<brief_summary>The purpose study examine safety tolerability multiple dose PF-04360365 administer approximately 10 minute Japanese patient mild-to-moderate Alzheimer 's disease characterize pharmacokinetics PF-04360365 follow administration multiple dose Japanese patient mild-to-moderate Alzheimer 's disease .</brief_summary>
	<brief_title>Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Japanese male female non childbearing potential , age &gt; = 50 Diagnosis probable Alzheimer 's disease , consistent criterial : National Institute Neurological Communicable Disease Stroke Alzheimer 's Disease Related Disorders Association ( NINCDSADRDA ) Diagnostic Statistical Manual Mental Disorders ( DSM IV ) Minimental status exam score 1626 inclusive RosenModified Hachinski Ischemia Score &lt; = 4 Diagnosis history demential neurodegenerative disorder Diagnosis history clinically significant cerebrovascular disease Specific find magnetic resonance imaging ( MRI ) ; cortical infarct , micro hemorrhage , multiple white matter lacunes , extensive white matter abnormality History autoimmune disorder History allergic anaphylactic reaction</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>amyloid</keyword>
	<keyword>antibody</keyword>
	<keyword>Japanese</keyword>
</DOC>